The higher levels of DNA-NE and DNA-MPO in patients with AE and severe bronchiectasis indicated that neutrophilic inflammation and NET formation are candidate biomarkers for evaluating bronchiectasis severity. This evidence concerns the gene ELANE and bronchiectasis.